These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 30497067)

  • 1. Inhibition of microRNA-200a Upregulates the Expression of Striatal Dopamine Receptor D2 to Repress Apoptosis of Striatum via the cAMP/PKA Signaling Pathway in Rats with Parkinson's Disease.
    Wu DM; Wang S; Wen X; Han XR; Wang YJ; Shen M; Fan SH; Zhuang J; Zhang ZF; Shan Q; Li MQ; Hu B; Sun CH; Lu J; Zheng YL
    Cell Physiol Biochem; 2018; 51(4):1600-1615. PubMed ID: 30497067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-326 Inhibits Apoptosis and Promotes Proliferation of Dopaminergic Neurons in Parkinson's Disease Through Suppression of KLK7-Mediated MAPK Signaling Pathway.
    Zhang Y; Xu W; Nan S; Chang M; Fan J
    J Mol Neurosci; 2019 Oct; 69(2):197-214. PubMed ID: 31270675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total glucosides of paeony (TGP) extracted from Radix Paeoniae Alba exerts neuroprotective effects in MPTP-induced experimental parkinsonism by regulating the cAMP/PKA/CREB signaling pathway.
    Zheng M; Liu C; Fan Y; Shi D; Jian W
    J Ethnopharmacol; 2019 Dec; 245():112182. PubMed ID: 31445131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulated expression of microRNA-329 inhibits apoptosis of nigral dopaminergic neurons by regulating CDKN2D expression via the FoxO3a signaling pathway in rats with Parkinson's disease.
    Liu YY; Zhang YN; Yang QS
    J Cell Physiol; 2018 Nov; 233(11):8617-8629. PubMed ID: 29761857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of lncRNA BACE1-AS improves dopamine-dependent oxidative stress in rats with Parkinson's disease by upregulating microRNA-34b-5p and downregulating BACE1.
    Li Y; Fang J; Zhou Z; Zhou Q; Sun S; Jin Z; Xi Z; Wei J
    Cell Cycle; 2020 May; 19(10):1158-1171. PubMed ID: 32308102
    [No Abstract]   [Full Text] [Related]  

  • 6. Total barley maiya alkaloids inhibit prolactin secretion by acting on dopamine D2 receptor and protein kinase A targets.
    Gong X; Tao J; Wang Y; Wu J; An J; Meng J; Wang X; Chen Y; Zou J
    J Ethnopharmacol; 2021 Jun; 273():113994. PubMed ID: 33711439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of transcription factor TCTP elevates microRNA-200a expression to restrain Myt1L expression, thereby improving neurobehavior and oxidative stress injury in cerebral palsy rats.
    He X; Liu Z; Pang Y; Xu W; Zhao L; Li H
    Cell Cycle; 2020 Apr; 19(8):855-869. PubMed ID: 32174219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-128 Protects Dopamine Neurons from Apoptosis and Upregulates the Expression of Excitatory Amino Acid Transporter 4 in Parkinson's Disease by Binding to AXIN1.
    Zhou L; Yang L; Li YJ; Mei R; Yu HL; Gong Y; Du MY; Wang F
    Cell Physiol Biochem; 2018; 51(5):2275-2289. PubMed ID: 30537735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of long noncoding RNA SNHG7 protects against inflammation and apoptosis in Parkinson's disease model by targeting the miR-425-5p/TRAF5/NF-κB axis.
    Zhang H; Wang Z; Hu K; Liu H
    J Biochem Mol Toxicol; 2021 Oct; 35(10):e22867. PubMed ID: 34369042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The anti-aging protein klotho alleviates injury of nigrostriatal dopaminergic pathway in 6-hydroxydopamine rat model of Parkinson's disease: Involvement of PKA/CaMKII/CREB signaling.
    Baluchnejadmojarad T; Eftekhari SM; Jamali-Raeufy N; Haghani S; Zeinali H; Roghani M
    Exp Gerontol; 2017 Dec; 100():70-76. PubMed ID: 29107062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G-protein coupled receptor 6 deficiency alters striatal dopamine and cAMP concentrations and reduces dyskinesia in a mouse model of Parkinson's disease.
    Oeckl P; Hengerer B; Ferger B
    Exp Neurol; 2014 Jul; 257():1-9. PubMed ID: 24747358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of microRNA-342-3p increases glutamate transporters and prevents dopaminergic neuron loss through activating the Wnt signaling pathway via p21-activated kinase 1 in mice with Parkinson's disease.
    Wu DM; Wang S; Wen X; Han XR; Wang YJ; Shen M; Fan SH; Zhuang J; Zhang ZF; Shan Q; Li MQ; Hu B; Sun CH; Lu J; Chen GQ; Zheng YL
    J Cell Physiol; 2019 Jun; 234(6):9033-9044. PubMed ID: 30362546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The subthalamic activity and striatal monoamine are modulated by subthalamic stimulation.
    Yamamoto T; Uchiyama T; Sakakibara R; Taniguchi J; Kuwabara S
    Neuroscience; 2014 Feb; 259():43-52. PubMed ID: 24291727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppressed microRNA-96 inhibits iNOS expression and dopaminergic neuron apoptosis through inactivating the MAPK signaling pathway by targeting CACNG5 in mice with Parkinson's disease.
    Dong Y; Han LL; Xu ZX
    Mol Med; 2018 Nov; 24(1):61. PubMed ID: 30486773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-200a Affects the Proliferation of Airway Smooth Muscle Cells and Airway Remodeling by Targeting FOXC1 via the PI3K/AKT Signaling Pathway in Ovalbumin-Induced Asthmatic Mice.
    Liu Y; Miao Y; Gao X; Wang YY; Wang H; Zheng YW; Zhao ZY
    Cell Physiol Biochem; 2018; 50(6):2365-2389. PubMed ID: 30423573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-synuclein interferes with cAMP/PKA-dependent upregulation of dopamine β-hydroxylase and is associated with abnormal adaptive responses to immobilization stress.
    Kim S; Park JM; Moon J; Choi HJ
    Exp Neurol; 2014 Feb; 252():63-74. PubMed ID: 24252179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased energy expenditure and activated β3-AR-cAMP-PKA signaling pathway in the interscapular brown adipose tissue of 6-OHDA-induced Parkinson's disease model rats.
    Lian H; Zhou L; Zhang Y; Song YH; Zhang YM; Cao ZH; Wang ZY
    Anat Rec (Hoboken); 2021 Apr; 304(4):704-713. PubMed ID: 32865327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A potential target for the treatment of Parkinson's disease: effect of lateral habenula lesions.
    Han B; Jin HJ; Song MY; Wang T; Zhao H
    Parkinsonism Relat Disord; 2014 Nov; 20(11):1191-5. PubMed ID: 25219971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. microRNA-208a in an early stage myocardial infarction rat model and the effect on cAMP-PKA signaling pathway.
    Feng G; Yan Z; Li C; Hou Y
    Mol Med Rep; 2016 Aug; 14(2):1631-5. PubMed ID: 27314868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential enhancement of ERK, PKA and Ca
    Mariani LL; Longueville S; Girault JA; Hervé D; Gervasi N
    Neurobiol Dis; 2019 Oct; 130():104506. PubMed ID: 31220556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.